Marex Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221M Sell
817,599
-584,677
-42% -$174M 1.4% 14
2025
Q4
$463M Buy
1,402,276
+343,280
+32% +$116M 2.91% 1
2025
Q3
$366M Buy
1,058,996
+782,933
+284% +$237M 2.58% 9
2025
Q2
$86.1M Sell
276,063
-56,120
-17% -$21.4M 0.75% 28
2025
Q1
$174M Buy
332,183
+168,629
+103% +$86.2M 3.33% 5
2024
Q4
$82.7M Sell
163,554
-94,567
-37% -$53.7M 1.41% 19
2024
Q3
$151M Buy
258,121
+58,779
+29% +$33.2M 3.44% 7
2024
Q2
$102M Buy
199,342
+71,967
+57% +$35.3M 2.73% 8
2024
Q1
$63M Buy
127,375
+122,011
+2,275% +$62M 2.05% 10
2023
Q4
$2.82M Buy
+5,364
New +$2.86M 0.11% 131

Other funds holding UNH

Marex Group's UNH Position: Q1 2026 in Review

Marex Group reduced its UnitedHealth (UNH) stake by 42% in Q1 2026, selling an estimated $174M and leaving 817,599 shares worth $221M. The position accounts for 1.4% of the portfolio, ranked #14.

Marex Group first reported a position in UNH in Q4 2023 and has held it in 10 quarters since. The position peaked at $463M in Q4 2025. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Marex Group held 817,599 shares of UnitedHealth worth $221M as of Q1 2026.
  • Marex Group sold 584,677 UnitedHealth shares in Q1 2026, an estimated $174M.
  • UnitedHealth made up 1.4% of Marex Group's portfolio in Q1 2026, its #14 holding.
  • Marex Group first reported a position in UnitedHealth in Q4 2023 and has held it in 10 quarters since.
  • Marex Group's UnitedHealth position peaked at $463M in Q4 2025.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.